They are SLC9A3R1, VCP, NDUFS1, EEF1D, HPCAL1, EZR, SET, HNRNPK with low expression level in primary RCC but high in the bone metastasis lesions of RCC patients (Fig. 5). Here, NHERF1 is linked to renal cell carcinoma.